Moleculin Announces Corporate Rebranding and Launch of New Website
Company reiterates commitment to solving some of the toughest challenges in highly resistant cancers and viruses and developing better treatments that can make a real impact in people’s lives HOUSTON, April 14, 2022 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or…
Comments Off on Moleculin Announces Corporate Rebranding and Launch of New Website